¿¬¼ö°­ÁÂ
´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 4ÀÏÂ÷ : 2024-06-16

´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 4ÀÏÂ÷ : 2024-06-16
±³À°ÀÏÀÚ : 2024-06-16
±³À°Àå¼Ò : COEX, Seoul, Korea  

±³À°ÁÖÁ¦ : APCN & KSN 2024 4ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  

À̸ÞÀÏ : ksn@ksn.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 2000¸í
Èñ¸ÁÆòÁ¡ : 3Á¡ (ÀÏ¹Ý 1Á¡ / Çʼö 2Á¡)

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 18 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í ¡áȸ¿ø: »çÀü(200,000)/ÇöÀå(250,000) ¡áºñȸ¿ø: »çÀü(250,000)/ ÇöÀå(250,000) ¡áPhysician in training/Nurse/Paramedics/Allied Health: »çÀü(100,000)/ ÇöÀå(125,000) *Student, ¸¸65¼¼ ÀÌ»ó ȸ¿ø: ¸éÁ¦


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 08:30~09:00 Can HIF Stabilizers Replace ESA in Patients with Hemodialysis? Pros vs. Cons ±èÁöÀº(°í·Á´ëÇб³ ±¸·Îº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 09:00~09:30 CKD-MBD Management: About the New Phosphate Binder Ȳ¼±´ö(ÀÎÇϴ뺴¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 09:30~10:00 Strategies for Achieving High Volume HDF Á¶¾ÆÁø(ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø)

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 10:30~11:00 Monitoring and Surveillance in Hemodialysis Access ±èÇü´ö(°¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 11:00~11:30 Vascular Ultrasound ±¸»ó°Ç(»ý¸í¼±ÀÇ¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 11:30~12:00 Application of Ultrasound in Nephrology Other than Vascular Ultrasound ±èÀºÁ¤(ÇѸ²´ëÇб³ µ¿Åº¼º½Éº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 08:30~09:00 Ç÷¾×Åõ¼®¸·ÀÇ ±¸Á¶¿Í ¼º´É ¹× °¡Àå ÀûÇÕÇÑ Åõ¼®¸·ÀÇ ¼±ÅÃÀº ÀÌÀåÇÑ(ºÐ´çÁ¦»ýº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 09:00~09:30 Current Evidence of Anticoagulation Therapy in Hemodialysis Patient ¹ÚÇýÀÎ(ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 09:30~10:00 Ç÷¾×Åõ¼®À» À§ÇÑ ¼öÁú°ü¸® ¹× Åõ¼®Àåºñ À¯Áö¸¦ À§ÇÑ ¼Òµ¶Áöħ ±èÀ¯°æ(¹Ú½ºÅÍ)

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 10:30~11:00 Åõ¼®È¯ÀÚÀÇ °¡·Á¿òÁõ °ü¸® Á¤º¸¿µ(ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 11:00~11:30 ÀÚµ¿º¹¸·Åõ¼®(APD)ÀÇ ÀÌÇØ¿Í °£È£ °û¹ÌÇý(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 11:30~12:00 Ç÷¾×Åõ¼® ÁßȯÀÚ °ü¸® ÀÌÇö¿µ(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 08:30~08:50 °í·É ȯÀÚÀÇ Åõ¼® À¯º¸¿Í °ü·ÃÇÑ À±¸®Àû ±Ç°í¾È ¼±ÀοÀ(¿¹¼öº´¿ø) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 08:50~09:10 °í·É ȯÀÚÀÇ Åõ¼® Áß´Ü°ú °ü·ÃÇÑ À±¸®Àû ±Ç°í¾È ±è¼­¸°(¾ç»êºÎ»ê´ëÇб³º´¿ø) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 09:10~09:30 °í·É ȯÀÚÀÇ Åõ¼® À¯º¸¿Í Áß´Ü°ú °ü·ÃÇÑ ÇØ¿Ü ±Ç°í¾È¿¡ ´ëÇÑ À±¸®Àû Á¢±Ù ¹× ºñ±³ ºÐ¼® ÃÖÀº°æ(°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 09:30~10:00 °í·É ȯÀÚÀÇ Åõ¼® À¯º¸¿Í Áß´Ü ±Ç°í¾È¿¡ ´ëÇÑ À±¸®Àû °í·Á»çÇ× ÀÌÀº¿µ(ºÎ»ê °¡Å縯´ëÇб³) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 10:00~10:30 °í·É ȯÀÚÀÇ Åõ¼® À¯º¸¿Í Áß´Ü ¶§ º¸Á¸ÄáÆÏ°ü¸®ÀÇ À±¸®Àû °í·Á»çÇ× ¹× Çʿ伺 ½Å¼ºÁØ(µ¿±¹´ëÇб³ Àϻ꺴¿ø) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 10:30~10:50 ADPKD Treatment and New European Guidelines on Tolvaptan Vladimir Tesar(Charles University)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 10:50~11:10 Genetic- and Kidney Disease-related Asymptomatic Hyperuricemial Mechanisms and Clinical Implications Stephanie Steiger(LMU Hospital)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 11:10~11:30 Modeling of Genetic Kidney Disease and Development of New Therapeutics Using Patient Derived Induced Pluripotent Stem Cells Á¤º´ÇÏ(°¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 11:30~11:50 Current Treatment Status of Fabry Nephropathy in Korea ÀÌÇÏÁ¤(Harvard Medical School)

Åä·Ð 06¿ù 16ÀÏ Room 3 11:50~12:00 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 4 08:30~09:50 KRCP: The Current and the Future Hakmmok Kang, Kent Doi, Ming-Zhi Zhang, Çã¼±(Vanderbilt University, The University of Tokyo Graduate School of Medicine, ÇѸ²´ëÇб³)

Åä·Ð 06¿ù 16ÀÏ Room 4 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 4 10:30~11:00 Emergency Preparedness and Kidney Disease - Sharing Know-Hows of ISN RDPWG Ali Abu-Alfa(American University of Beirut)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 4 11:00~11:30 Dietary Plan for Korean Renal Hemodialysis Patients in a Disaster Emergency Situation ÀåÀ¯¹Ì(¿ï»ê´ëÇб³ ½ÄÇ°¿µ¾çÇаú)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 4 11:30~12:00 Emergency Medical System for Disaster Response in Hospitals (Centered on Artificial Kidney Units) ÃÖ¿íÁø(¿ï»ê´ëÇб³º´¿ø ÀÀ±ÞÀÇÇаú)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 08:30~08:50 Conservative Kidney Management & Palliativa Care: Dialysis Withhold and Withdrawal ½Å¼ºÁØ(µ¿±¹´ëÇб³ Àϻ꺴¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 08:50~09:10 Strategies to Increase Kidney Transplantation Mai-Szu Wu(Taipei Medical University)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 09:10~09:30 Patient Selection and Prescription of Hemodiafiltration Ikuto Masakane(Yabuki Hospital)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 09:30~09:50 PD-first Policy in Hong Kong: Pros and Cons Philip Kam-Tao Li(Prince of Wales Hospital)

Åä·Ð 06¿ù 16ÀÏ Room 5 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 10:30~10:50 HD VA Endovascular Thrombectomy, Tips for Beginners ³ª±â·®(Ãæ³²´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 10:50~11:10 Ultrasound of Kidneys and Bladder: Clinical Case Scenarios Vandana Niyyar(Emory University School of Medicine)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 11:10~11:30 Native Fistula Should Remain the First Choice of Vascular Access for Elderlies Hideki Kawanishi(Tsuchiya General Hospital)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 11:30~11:50 Examination of Vascular Access: Best Practices and Tools Jernej Pajek(University Medical Center Ljubljana)

Åä·Ð 06¿ù 16ÀÏ Room 5 11:50~12:00 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 6 09:00~09:30 Differences Between OPO Structures and Roles and Their Advantages and Disadvantages: (US vs Spain vs Australia) Stefan Tullius(Harvard Medical School)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 6 09:30~10:00 Key Foundations for OPO Success I: Ethics, Compliance, Data Integrity, and Healthcare Collaboration Ghazali Ahmad(National Heart Institute)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 6 10:00~10:30 Key Foundations for OPO Success II: Comprehensive Training for Coordinators Dong Van He(Vietnam National Coordinating Center for Human Organ Transplantation (VNHOT))

ÈÞ½Ä 06¿ù 16ÀÏ 10:30~11:00 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 6 11:00~11:30 Key Foundations for OPO Success III: Cultural Awareness and Public Engagement Yingyos Avihingsanon(Chulalongkorn University)

Åä·Ð 06¿ù 16ÀÏ Room 6 11:30~12:00 Panel Discussion: Country Experience Cons and Pros in OPO All Speaker()

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) 2023³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù) : 2023-05-20

±³À°ÀÏÀÚ : 2023-05-20 ±³À°Àå¼Ò : ¿Â¶óÀÎ (VOD ´çÀÏ 24½Ã°£ ¼ÛÃâ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2023³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù)ÁÖÃÖ±â°ü : ¼­¿ïƯ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,277 , ´ñ±Û¼ö : 0

[¼­¿ï] 2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾ö : 2024-04-20

±³À°ÀÏÀÚ : 2024-04-20 ±³À°Àå¼Ò : °­µ¿°æÈñ´ëÇб³º´¿ø º°°üµ¿ 4Ãþ Â÷ÈÄ¿µÈ¦ ±³À°ÁÖÁ¦ : 2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : °­µ¿°æÈñ´ëÇб³º´¿ø ½Ã

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,573 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,909 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ BPEX 5Ãþ ÄÁÆÛ·±½ºÈ¦ ±³À°ÁÖÁ¦ : 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇÑ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,854 , ´ñ±Û¼ö : 0

[Àü³²] 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-04-11

±³À°ÀÏÀÚ : 2024-04-11 ±³À°Àå¼Ò : ¿©¼ö ¿¢½ºÆ÷ ÄÁº¥¼Ç¼¾ÅÍ ¿¢½ºÆ÷Ȧ ±³À°ÁÖÁ¦ : 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 1ÀÏÂ÷ÁÖÃÖ±â°ü : ´ëÇѸ鿪ÇÐȸ ´ã´çÀÚ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,717 , ´ñ±Û¼ö : 0